PubMed

Intravitreal triamcinolone acetonide for exudative age related macular degeneration.

Jonas JB, Kreissig I, Hugger P, Sauder G, Panda-Jonas S, Degenring R.

Br J Ophthalmol. 2003 Apr;87(4):462-8.PMID: 12642311 [PubMed - indexed for MEDLINE]Related articlesFree article

Intravitreal reinjection of triamcinolone for exudative age-related macular degeneration.

Jonas JB, Akkoyun I, Budde WM, Kreissig I, Degenring RF.

Arch Ophthalmol. 2004 Feb;122(2):218-22.PMID: 14769599 [PubMed - indexed for MEDLINE]Related articles

Intereye difference in exudative age-related macular degeneration with minimally classic or occult subfoveal neovascularization after unilateral intravitreal injection of triamcinolone acetonide.

Jonas JB, Spandau UH, Harder B, Vossmerbaeumer U, Kamppeter BA.

Am J Ophthalmol. 2005 Jun;139(6):1073-9.PMID: 15953439 [PubMed - indexed for MEDLINE]Related articles

Cataract surgery combined with intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Budde WM, Degenring RF.

Eur J Ophthalmol. 2005 May-Jun;15(3):329-35.PMID: 15945000 [PubMed - indexed for MEDLINE]Related articles

Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.

Jonas JB, Kreissig I, Degenring RF.

Br J Ophthalmol. 2004 Dec;88(12):1557-62.PMID: 15548812 [PubMed - indexed for MEDLINE]Related articlesFree article

Visual acuity change after intravitreal triamcinolone in various types of exudative age-related macular degeneration.

Jonas JB, Strueven V, Kamppeter BA, Harder B, Spandau UH, Schlichtenbrede F.

J Ocul Pharmacol Ther. 2006 Oct;22(5):370-6.PMID: 17076632 [PubMed - indexed for MEDLINE]Related articles

Repeated intravitreal injection of triamcinolone for exudative age-related macular degeneration.

Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B.

Ophthalmic Res. 2006;38(6):324-8. Epub 2006 Oct 13.PMID: 17047404 [PubMed - indexed for MEDLINE]Related articles

[Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases]

Jonas JB, Kreissig I, Kamppeter B, Degenring RF.

Ophthalmologe. 2004 Feb;101(2):113-20. Review. German. PMID: 14991306 [PubMed - indexed for MEDLINE]Related articles

Duration of the effect of intravitreal triamcinolone acetonide in eyes with exudative age-related macular degeneration.

Jonas JB, Spandau UH, Kamppeter BA, Degenring RF, Kreissig I, Akkoyun I, Vossmerbaeumer U.

J Ocul Pharmacol Ther. 2006 Jun;22(3):194-9.PMID: 16808681 [PubMed - indexed for MEDLINE]Related articles

Repeated intravitreal high-dosage injections of triamcinolone acetonide for diffuse diabetic macular edema.

Jonas JB, Spandau UH, Kamppeter BA, Vossmerbaeumer U, Harder B, Sauder G.

Ophthalmology. 2006 May;113(5):800-4. Epub 2006 Mar 13.PMID: 16530840 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

Jonas JB.

Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. Review.PMID: 16396641 [PubMed - indexed for MEDLINE]Related articles

Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.

Jonas JB, Spandau UH, Kamppeter BA, Harder B.

Eye (Lond). 2007 Mar;21(3):387-94. Epub 2006 Jan 13.PMID: 16410809 [PubMed - indexed for MEDLINE]Related articles

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Degenring R.

Br J Ophthalmol. 2003 Jan;87(1):24-7.PMID: 12488256 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized clinical trial of a single dose of intravitreal triamcinolone acetonide for neovascular age-related macular degeneration: one-year results.

Gillies MC, Simpson JM, Luo W, Penfold P, Hunyor AB, Chua W, Mitchell P, Billson F.

Arch Ophthalmol. 2003 May;121(5):667-73.PMID: 12742844 [PubMed - indexed for MEDLINE]Related articles

Prospective, randomized clinical trial of intravitreal triamcinolone treatment of neovascular age-related macular degeneration: one-year results.

Lee J, Freeman WR, Azen SP, Chung EJ, Koh HJ.

Retina. 2007 Nov-Dec;27(9):1205-13.PMID: 18046226 [PubMed - indexed for MEDLINE]Related articles

Exudative age-related macular degeneration treated by intravitreal triamcinolone acetonide. A prospective comparative nonrandomized study.

Jonas JB, Degenring RF, Kreissig I, Friedemann T, Akkoyun I.

Eye (Lond). 2005 Feb;19(2):163-70.PMID: 15218517 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide for diabetic macular edema.

Chieh JJ, Roth DB, Liu M, Belmont J, Nelson M, Regillo C, Martidis A.

Retina. 2005 Oct-Nov;25(7):828-34.PMID: 16205559 [PubMed - indexed for MEDLINE]Related articles

Intravitreal triamcinolone acetonide for exudative age-related macular degeneration among Japanese patients.

Ito M, Okubo A, Sonoda Y, Yamakiri K, Sakamoto T.

Ophthalmologica. 2006;220(2):118-24.PMID: 16491035 [PubMed - indexed for MEDLINE]Related articles

Intravitreal bevacizumab versus triamcinolone acetonide for exudative age-related macular degeneration.

Jonas JB, Ihloff AK, Harder B, Kreissig I, Schlichtenbrede F, Libondi T, Spandau UH, Vossmerbaeumer U.

Ophthalmic Res. 2009;41(1):21-7. Epub 2008 Oct 13.PMID: 18849638 [PubMed - indexed for MEDLINE]Related articles

Cataract surgery after intravitreal injection of triamcinolone acetonide.

Jonas JB, Kreissig I, Degenring RF.

Eye (Lond). 2004 Apr;18(4):361-4.PMID: 15069430 [PubMed - indexed for MEDLINE]Related articles